Sage Bionetworks News
- Commons Congress presentations and videos available (23 April 2012)
- Young Investigator Awards (8 Feb 2012)
- 3rd Commons Congress (15 Dec 2011)
- Thinking outside the Genome (4 Oct 2011)
- Leveraging Crowdsourcing to Facilitate the Discovery of New Medicines (22 June 2011)
- Commons Principles (13 May 2011)
Sage Bionetworks Media Coverage
- Sage Bionetworks Moves from Thinking to Doing by Luke Timmerman (18 April 2012)
- Drug-discovery revolution by Maureen O'Hagen (11Feb 2012)
- The Visionary by Jocelyn Kaiser (9 Feb 2012)
- Citizen Scientists by Amy Dockser Marcus
(3 Dec 2011) - Who owns the data? by Susan Love
(8 Nov 2011) - Partnering between pharma peers on the rise by Asher Mullard (3 Aug 2011)
- Making the Case for Precompetitive Clinical Development by Chris Cain (19 May 2011)
Sage Bionetworks on Twitter, Facebook & Tumblr.
Sage Bionetworks
News & Information
Media releases, newsletters, announcements, and multimedia links
Latest News stories
23 April 2012 - 3rd Commons Congress. The 2012 Sage Bionetworks Commons Congress presentations and videos are now available on line.
18 April 2012 -"Sage Bionetworks Moves from Thinking Stage to Doing Stage" Luke Timmerman has written a detailed update on the continued growth and evolution of Sage Bionetworks and its initiatives in Xconomy.
February 2012 - Seattle TimesMagazine Cover Story. Maureen O'Hagen has done a wonderful story on Stephen Friend and his formation of Sage Bionetworks with a goal that was nothing short of revolutionizing the way drug discovery is done so patients don't have to wait for help.
9 February 2012 - Stephen Friend profiled in Science. Jocelyn Kaiser has written an extensive profile of Sage Bionetworks and Stephen Friend in Science. Her summary, "Seeking to spur drug development, Stephen Friend has launched a daring series of initiatives to make biomedical research more open and effective."
8 February 2012 - Young Investigator Travel Awards are available for the April 2012 Sage Bionetworks Commons Congress. The awards will cover travel and accommodation expenses (there is no registration charge) and application can be made online.
4 October 2011- Democratization of Medicine. Stephen Friend has published a thoughtful essay in a special genomics edition of The Scientist entitled," Thinking outside the genome". It notes how the rise of -omics technology creates a new, albeit challenging, opportunity for scientists to work collectively with non-scientists to make substantive improvements in health care delivery.
3 August 2011 - Partnering between pharma peers on the rise. Asher Mullard has published a nice commentary in Nature Reviews Drug Discovery on the growing number of pharma to pharma partnerships and the role that Arch2POCM and Enlight Biosciences are playing in these consortia.
22 June 2011 -Leveraging Crowdsourcing: Arch2POCM meeting report in Science Translational Medicine. Arch2POCM is a groundbreaking public-private partnership that is establishing an open, distributed pre-competitive drug discovery and development environment to accelerate therapeutic advances across the pharmaceutical industry. Thea Norman, Chas Bountra, Aled Edwards, Keith Yamamoto, and Stephen Friend have published a report on the exciting progress the nascent Arch2POCM initiative made at its April 2011 meeting in San Francisco. Through a special arrangement with Science Translational Medicine you can download a PDF of the full article for free by clicking on this link.
13 May 2011 - Public release of Commons Principles. This charter for open, contributor-driven genomic research and progressive community engagement was developed to define behaviors and processes for those working in the Commons computational environment as well as for researchers interested in cooperative, data-intensive science and patient advocacy. The Principles are an aspirational guide rather than a detailed roadmap (which will come from the activities of Community of Interest D over the next year.) This vision for the Commons is described in six principles emphasizing the; healthcare focus, open platform, respect for all stakeholders, proper attribution, transparent standards, and absence of IP barriers. The Principles have been approved by Congress attendees and the Sage Bionetworks Board of Directors. They are now open for public endorsement and comment. We invite supporters of open science and public engagement to add their voice: Commons Principles
Congress Videos and Presentations
Videos of the 2012 Sage Bionetworks Commons Congress Presentations are available on the Congress web site. You can view streaming video from fora.tv or download the video files directly to your computer. PDF copies of most presentations are also available for downloading.
News & Discussion Blog
Sage Bionetworks hosts a News and Discussion Forum to provide updates on its activities and as an on-line research community roundtable. The facility has multiple categories, moderated comments and full search, index and archive capacity for discussing genomic analysis and open access strategies. Sage Bionetworks welcomes inquires from anyone interested in contributing: info@sagebase.org.
Updates, Newsletter and Social Media
Sage Bionetworks provides updates on twitter as well as news on medical research, open science and genetics of interest to our community. Our twitter name is@sagebio and you can also follow us using the #Sagebio hashtag. The annual Sage Bionetworks Commons Congress uses the #SageCon hashtag and has been a rich source of updates and commentary during the April Congresses.
The Sage Bionetworks Facebook page has updates on Sage Bionetworks, links to interesting news and tabs with blog and twitter updates. You can also sign up for the Sage Bionetworks newsletter which is a concise summary of activities distributed several times a year. Newsletter subscription information is only used to send information on Sage Bionetworks and is never provided to third parties.